1PAN H Y, ZHU J H, GU Y,et al. Comparative effects ofrecombinant human brain natriuretic peptide and dobutamine onacute decompensated heart failure patients with different bloodBNP levels [ J]. BMC Cardiovasc Disord, 2014, 14: 31.
2§AHINM,PORTAKAL 0,KARAGOZ T,et al. Diagnosticperformance of BNP and NT-ProBNP measurements in childrenwith heart failure based on congenital heart defects and cardio-myopathies [J]. Clinical biochemistry, 2010, 43: 1278-1281.
3HIROYUKI T, YASUAKI D. Kidney function crucially affects B-type natriuretic peptide ( BNP) , N-terminal pro BNP and theirrelationship [J]. Eur J Clin Invest, 2014, 44(3) : 303-308.
4MCLLROY D R, WALLACE B, ROUBOS N, et al. Brainnatriuretic peptide (BNP) as a biomarker of myocardial ischemia-reper fusion injury in cardiac transplantation [ J ]. Journal ofcardio-thoracic and vascular anesthesia, 2010,24(6) : 939-945.
5GLEZEVA N, COLUER P, VOON V,et al. Attenuation ofmonocyte chemotaxis-a novel anti-inflammatory mechanism ofaction for the cardio-protective hormone B-type natriuretic peptide[J]. Cardiovasc Transl Res, 2013,6(4) : 545-557.
7HILL S A, BOOTH R A, SANTAGUIDA PL, et al. Use of BNPand NT-proBNP for the diagnosis of heart failure in the emergencydepartment: a systematic review of the evidence [ J]. Heart FailRev, 2014,19(4): 421438.
8HAROON J, FOUREAUX G, MARTINS A S, et al. Genderdifferences in normal left ventricle of adult FVB/N mice due tovariation in interleukins and natriuretic peptides expression levels[J]. Cytokine, 2015, 71(1) : 54-59.
9MADAMANCHI C, ALHOSAINI H, SUMIDA A, et al. Obesityand natriuretic peptides, BNP and NT-proBNP: mechanisms anddiagnostic implications for heart failure [ J]. Int J Cardiol,2014,176(3) : 611-617.
6Buchhom R, Hulpke-Wette M, Ruschewski W, et al. Effects of therapeutic beta blockade on myocardial function and cardiac remodeling in congenital cardiac disease. Cardiol Young, 2003, 13 : 36-43.
7Metra M, Nodari S, Parfinello G, et al. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure:clinic correlates and prognostic significance. Am Heart J, 2003, 145:292-299.
8Pritehett AM, Redfield MM. Beta-blockers: new standard therapy for heart failure. Mago Clin Pro, 2002, 77 : 839-845.
9Patterson JH, Rodgers JE. Expanding role of beta-blockade in the management of chronic heart failure. Pharmacotherapy, 2003,23 : 451-459.
10Bettencourt PM. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart, 2005, 91: 1489-1494.
